Literature DB >> 25751199

Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input.

Jill L Schwartz1, Debra H Weiner, Jaim Jou Lai, Ron G Frezieres, Mitchell D Creinin, David F Archer, Lynn Bradley, Kurt T Barnhart, Alfred Poindexter, Maggie Kilbourne-Brook, Marianne M Callahan, Christine K Mauck.   

Abstract

OBJECTIVE: To estimate contraceptive efficacy, safety, acceptability, and fit of a single-size diaphragm used with contraceptive gel.
METHODS: We conducted a multicenter trial in which 450 couples used the single-size diaphragm, 300 randomized to acid-buffering gel and 150 to nonoxynol-9, for at least 190 days and six menstrual cycles. Visits were at enrollment and after menstrual cycles 1, 3, and 6. Study outcomes included pregnancy probability, safety, acceptability, and fit. Pregnancy and safety were compared with an historical control group who used a standard diaphragm with these gels.
RESULTS: Most (439/450 [98%]) women could be fitted with the single-size diaphragm. A total of 421 of 450 (94%) provided follow-up. The 35 study pregnancies yielded 6-month Kaplan-Meier cumulative typical use pregnancy probabilities per 100 women with 95% confidence intervals (CIs) of 10.4 (6.9-14.0) for all users and 9.6 (5.5-13.6) and 12.5 (5.4-19.5) with acid-buffering gel and nonoxynol-9, respectively. Historical control analysis yielded a propensity score-adjusted estimate of this pregnancy probability for the single-size diaphragm of 11.3 compared with 10.7 per 100 women for the standard diaphragm ([rounded] difference 0.7, 95% CI -3.6 to 4.9). Approximately half (51%) reported at least one urogenital event but compared favorably to the standard diaphragm in historical control analysis. Most (282/342 [82%]) liked the diaphragm. Results suggest that if provided by a clinician, 94% (95% CI 92-96%) could insert, correctly position, and remove the diaphragm.
CONCLUSION: The single-size diaphragm was safe, as effective as a standard diaphragm, and acceptable when used with contraceptive gel. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00578877.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25751199     DOI: 10.1097/AOG.0000000000000721

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Mechanisms of action of currently available woman-controlled, vaginally administered, non-hormonal contraceptive products.

Authors:  B Todd Chappell; Brooke L Griffin; Brandon Howard
Journal:  Ther Adv Reprod Health       Date:  2022-07-07

2.  A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial.

Authors:  Michael A Thomas; B Todd Chappell; Bassem Maximos; Kelly R Culwell; Clint Dart; Brandon Howard
Journal:  Contracept X       Date:  2020-07-01

3.  Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception.

Authors:  Bhawana Shrestha; Alison Schaefer; Yong Zhu; Jamal Saada; Timothy M Jacobs; Elizabeth C Chavez; Stuart S Olmsted; Carlos A Cruz-Teran; Gabriela Baldeon Vaca; Kathleen Vincent; Thomas R Moench; Samuel K Lai
Journal:  Sci Transl Med       Date:  2021-08-11       Impact factor: 17.956

4.  In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models.

Authors:  Yu Liu; Fujin Yang; Linglin Feng; Long Yang; Lingyun Chen; Gang Wei; Weiyue Lu
Journal:  Acta Pharm Sin B       Date:  2017-05-09       Impact factor: 11.413

5.  Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception.

Authors:  Bhawana Shrestha; Kathleen Vincent; Alison Schaefer; Yong Zhu; Gracie Vargas; Massoud Motamedi; Kelsi Swope; Josh Morton; Carrie Simpson; Henry Pham; Miles B Brennan; Michael H Pauly; Larry Zeitlin; Barry Bratcher; Kevin J Whaley; Thomas R Moench; Samuel K Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

6.  A New Contraceptive Diaphragm in Niamey, Niger: A Mixed Methods Study on Acceptability, Use, and Programmatic Considerations.

Authors:  Ashley Jackson; Alexandra Angel; Abdoul-Razak Mahamadou Bagourmé; Moumouni Boubacar; Aminata Maazou; Harou Issoufa; Paul Bouanchaud
Journal:  Glob Health Sci Pract       Date:  2022-02-28

Review 7.  CE: An Evidence-Based Update on Contraception.

Authors:  Laura E Britton; Amy Alspaugh; Madelyne Z Greene; Monica R McLemore
Journal:  Am J Nurs       Date:  2020-02       Impact factor: 2.577

8.  The postcoital test in the development of new vaginal contraceptives†.

Authors:  Christine K Mauck; Kathleen L Vincent
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.